Publications
- Overcoming multidrug resistance in Dox-resistant neuroblastoma cell lines via treatment with HPMA copolymer conjugates containing anthracyclines and P-gp inhibitors2016 | Second Faculty of Medicine
- The synergistic effects of DNA-damaging drugs cisplatin and etoposide with a histone deacetylase inhibitor valproate in high-risk neuroblastoma cells2015 | Faculty of Science, Second Faculty of Medicine
- Metallomics of brain tumors - new diagnostic and therapeutic possibilities2015 | Faculty of Science, Second Faculty of Medicine
- Vacuolar-ATPase-mediated intracellular sequestration of ellipticine contributes to drug resistance in neuroblastoma cells2015 | Faculty of Science, Second Faculty of Medicine
- Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells2012 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells2012 | Second Faculty of Medicine
- Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma2011 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport
- Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma2011 | Second Faculty of Medicine
- Valproic Acid in the Complex Therapy of Malignant Tumors2010 | Second Faculty of Medicine
- An electrochemical study of interaction of an anticancer alkaloid ellipticine with DNA2010 | Second Faculty of Medicine
Loading network view...